Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?5.5 WB, SLA? 10mm, RXD: medical device reports filed with FDA

650 reports name it, 2021–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

650
device reports naming the brand
0% of all MAUDE reports · about 118 a year
222
reports, 12 months to August 2026
175 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 650 reports that name the brand "BLX ?5.5 WB, SLA? 10mm, RXD" (endosseous dental implant), received between January 2021 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

222 reports arrived in the 12 months to August 2026, up 27% from 175 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (58.9%), loss of osseointegration (14.2%) and difficult to insert (4.2%). The patient problems coded most often are fibrosis, pain and swelling/ edema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01937Sep 2021: 4Oct 2021: 1Nov 2021: 2Dec 2021: 22022Jan 2022: 1Feb 2022: 0Mar 2022: 3Apr 2022: 5May 2022: 4Jun 2022: 7Jul 2022: 8Aug 2022: 3Sep 2022: 8Oct 2022: 1Nov 2022: 7Dec 2022: 72023Jan 2023: 7Feb 2023: 5Mar 2023: 5Apr 2023: 5May 2023: 8Jun 2023: 3Jul 2023: 11Aug 2023: 4Sep 2023: 13Oct 2023: 9Nov 2023: 13Dec 2023: 82024Jan 2024: 13Feb 2024: 6Mar 2024: 15Apr 2024: 12May 2024: 13Jun 2024: 14Jul 2024: 8Aug 2024: 11Sep 2024: 13Oct 2024: 10Nov 2024: 11Dec 2024: 162025Jan 2025: 16Feb 2025: 20Mar 2025: 15Apr 2025: 12May 2025: 0Jun 2025: 37Jul 2025: 16Aug 2025: 9Sep 2025: 22Oct 2025: 6Nov 2025: 9Dec 2025: 192026Jan 2026: 10Feb 2026: 22Mar 2026: 21Apr 2026: 32May 2026: 11Jun 2026: 20Jul 2026: 30Aug 2026: 20

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0911812021: 1620212022: 5420222023: 9120232024: 14220242025: 18120252026: 1662026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%650
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report71.4%464
Voluntary report0%0
User facility report0%0
Distributor report28.6%186
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate38358.9%62.8%
Loss of osseointegration9214.2%22.4%
Difficult to insertthe device was hard to insert274.2%0.4%
Separation failure30.5%0.1%
Fracturea broken bone20.3%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis21733.4%
Painpain, site not specified11217.2%
Swelling/ edema324.9%
Inflammationinflammation304.6%
Hyperresponsive to stimuli223.4%
Hemorrhage/blood loss/bleeding192.9%
Abscessa collection of pus162.5%
Fistula101.5%
Numbnessnumbness81.2%
Hypersensitivity/allergic reaction10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?5.5 WB, SLA? 10mm, RXDProduct code DZEAll MAUDE reports
Reports6503,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer71.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?5.5 WB, SLA? 10mm, RXD reports

How many FDA reports name BLX ?5.5 WB, SLA? 10mm, RXD?

650 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 222 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (58.9%), loss of osseointegration (14.2%), difficult to insert (4.2%), separation failure (0.5%) and fracture (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (71.4%) and distributor reports (28.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?5.5 WB, SLA? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.